HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Autosomal recessive juvenile parkinsonism Cys212Tyr mutation in parkin renders lymphocytes susceptible to dopamine- and iron-mediated apoptosis.

Abstract
Mutations in parkin are implicated in the pathogenesis of autosomal recessive juvenile parkinsonism (AR-JP) disease. We show that homozygote Cys212Tyr parkin mutation in AR-JP patients renders lymphocytes sensitive to dopamine, iron and hydrogen peroxide stimuli. Indeed, dopamine-induced apoptosis by four alternative mechanisms converging on caspase-3 activation and apoptotic morphology: (1) NF-kappaB-dependent pathway; mitochondrial dysfunction either by (2) H(2)O(2) or (3) hydroxyl exposure and (4) increase of unfolded-protein stress. We also demonstrate that 17beta-estradiol and testosterone prevent homozygote lymphocytes from oxidative stressors-evoked apoptosis. These results may contribute to understanding the relationship between genetic and environmental factors and iron in AR-JP.
AuthorsMarlene Jimenez Del Rio, Sonia Moreno, Gloria Garcia-Ospina, Omar Buritica, Carlos S Uribe, Francisco Lopera, Carlos Velez-Pardo
JournalMovement disorders : official journal of the Movement Disorder Society (Mov Disord) Vol. 19 Issue 3 Pg. 324-30 (Mar 2004) ISSN: 0885-3185 [Print] United States
PMID15022188 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2003 Movement Disorder Society
Chemical References
  • Dipeptides
  • NF-kappa B
  • Transcription Factors
  • cysteinyltyrosine
  • Iron
  • Ubiquitin-Protein Ligases
  • parkin protein
  • Dopamine
Topics
  • Apoptosis (drug effects)
  • DNA Mutational Analysis
  • Dipeptides (genetics)
  • Dopamine (metabolism)
  • Female
  • Humans
  • Iron (pharmacology)
  • Lymphocytes (metabolism)
  • Male
  • Membrane Potentials
  • Middle Aged
  • NF-kappa B (genetics)
  • Parkinsonian Disorders (genetics, pathology)
  • Point Mutation (genetics)
  • Transcription Factors
  • Ubiquitin-Protein Ligases (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: